Increased recall rate at screening for congenital hypothyroidism in breast fed infants born to iodine overloaded mothers

Skin disinfection with povidine-iodine (PVP-I) is widely used in obstetrics. We evaluated the influence of PVP-I in mothers at delivery on the serum thyroid stimulating hormone concentrations of their infants at the time of screening for congenital hypothyroidism. The study covered 4745 infants who...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 1988-10, Vol.63 (10), p.1207-1210
Main Authors: Chanoine, J P, Boulvain, M, Bourdoux, P, Pardou, A, Van Thi, H V, Ermans, A M, Delange, F
Format: Article
Language:English
Subjects:
Biological and medical sciences
Breast Feeding
Congenital Hypothyroidism
Control Groups
Delivery, Obstetric
Disinfection
Drug toxicity and drugs side effects treatment
False Positive Reactions
Female
Humans
Hypothyroidism - blood
Hypothyroidism - prevention & control
Infant, Newborn
Infants
Iodides
Iodine
Mass Screening
Medical sciences
Miscellaneous (drug allergy, mutagens, teratogens...)
Mothers
Pharmacology. Drug treatments
Povidone - analogs & derivatives
Povidone-Iodine - pharmacokinetics
Skin Absorption
Thyroid
Thyrotropin - blood
Young Children
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Skin disinfection with povidine-iodine (PVP-I) is widely used in obstetrics. We evaluated the influence of PVP-I in mothers at delivery on the serum thyroid stimulating hormone concentrations of their infants at the time of screening for congenital hypothyroidism. The study covered 4745 infants who were either breast fed (3659, 77%) or bottle fed (1086, 23%); 3086 (65%) of them were born to mothers with no iodine overload (controls) and 1659 (35%) to mothers with iodine overload. Compared with the control group, the breast and bottle fed infants born to mothers with iodide overload had a shift of neonatal thyroid stimulating hormone concentration towards high values. The shift was maximal in the breast fed infants with a 25 to 30 fold increase in the recall rate at screening for congenital hypothyroidism (serum thyroid stimulating hormone greater than 50 mU/l) while in the bottle fed infants, the recall rate was barely modified. In conclusion, the use of PVP-I in mothers at delivery induces a transient impairment of thyroid function in their infants, especially if breast fed. This situation is detrimental to screening for congenital hypothyroidism. Consequently PVP-I is not recommended in obstetrics.
ISSN:0003-9888
1468-2044
DOI:10.1136/adc.63.10.1207